Risk of recurrent venous thromboembolism according to baseline risk factor profiles

Martin H. Prins, Anthonie W. A. Lensing, Paolo Prandoni, Philip S. Wells, Peter Verhamme, Jan Beyer-Westendorf, Rupert Bauersachs, Henri Bounameaux, Timothy A. Brighton, Alexander T. Cohen, Bruce L. Davidson, Herve Decousus, Ajay K. Kakkar, Bonno van Bellen, Akos F. Pap, Martin Homering, Miriam Tamm, Jeffrey Weitz*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

39 Citations (Web of Science)
Original languageEnglish
Pages (from-to)788-796
Number of pages9
JournalBlood advances
Volume2
Issue number7
DOIs
Publication statusPublished - 10 Apr 2018

Keywords

  • INFLAMMATORY-BOWEL-DISEASE
  • ANTITHROMBOTIC THERAPY
  • RIVAROXABAN
  • THROMBOSIS
  • PREVENTION
  • ASPIRIN
  • WOMEN
  • VTE

Cite this